Biallelic variants in CRIPT cause a Rothmund-Thomson-like syndrome with increased cellular senescence.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Averdunk Luisa, Huetzen Maxim A, Moreno-Andrés Daniel, Kalb Reinhard, McKee Shane, Hsieh Tzung-Chien, Seibt Annette, Schouwink Marten, Lalani Seema, Faqeih Eissa Ali, Brunet Theresa, Boor Peter, Neveling Kornelia, Hoischen Alexander, Hildebrandt Barbara, Graf Elisabeth, Lu Linchao, Jin Weidong, Schaper Joerg, Omer Jamal A, Demaret Tanguy, Fleischer Nicole, Schindler Detlev, Krawitz Peter, Mayatepek Ertan, Wieczorek Dagmar, Wang Lisa L, Antonin Wolfram, Jachimowicz Ron D, von Felbert Verena, Distelmaier Felix
Аннотация
METHODS: Two newly identified and 4 published individuals with CRIPT variants were systematically compared with those with RTS using clinical data, computational analysis of photographs, histologic analysis of skin, and cellular studies on fibroblasts.
RESULTS: All CRIPT individuals fulfilled the diagnostic criteria for RTS and additionally had neurodevelopmental delay and seizures. Using computational gestalt analysis, CRIPT individuals showed greatest facial similarity with individuals with RTS. Skin biopsies revealed a high expression of senescence markers (p53/p16/p21) and the senescence-associated ß-galactosidase activity was elevated in CRIPT-deficient fibroblasts. RECQL4- and CRIPT-deficient fibroblasts showed an unremarkable mitotic progression and unremarkable number of mitotic errors and no or only mild sensitivity to genotoxic stress by ionizing radiation, mitomycin C, hydroxyurea, etoposide, and potassium bromate.
CONCLUSION: CRIPT causes an RTS-like syndrome associated with neurodevelopmental delay and epilepsy. At the cellular level, RECQL4- and CRIPT-deficient cells display increased senescence, suggesting shared molecular mechanisms leading to the clinical phenotypes.